The -374T/a variant of the RAGE gene promoter is associated with clinical restenosis after coronary stent placement

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 4, 2007, Pages 771-777

  Falcone, C ^a,b   Emanuele, E ^b   Buzzi, M P ^a   Ballerini, L ^a   Repetto, A ^a   Canosi, U ^a   Mazzucchelli, I ^b   Schirinzi, S ^a   Sbarsi, I ^b   Boiocchi, C ^b   Cuccia, M ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Diabetes; RAGE; Restenosis; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; CLOPIDOGREL; DNA; TICLOPIDINE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CORONARY STENT; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART PROTECTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTENOSIS;

EID: 37749009143     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000413     Document Type: Article

References (32)

1. Karthikeyan G. and B. Bhargava. 2004. Prevention of restenosis after coronary angioplasty. Curr. Opin. Cardiol. 19:500.
2. Drachman D.E. and D.I. Simon. 2005. Inflammation as a mechanism and therapeutic target for in-stent restenosis. Curr. Atheroscler. Rep. 7:44.
3. Toutouzas K., A. Colombo and C. Stefanadis. 2004. Inflammation and restenosis after percutaneous coronary interventions. Eur. Heart J. 25:1679.
4. Sakaguchi T., S.F. Yan, S.D. Yan, D. Belov, L.L. Rong, M. Sousa, M. Andrassy, S.P. Marso, S. Duda, B. Arnold, B. Liliensiek, P.P. Nawroth, D.M. Stern, A.M. Schmidt and Y. Naka. 2003. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Invest. 111:959.
5. Zhou Z., K. Wang, M.S. Penn, S.P. Marso, M.A. Lauer, F. Forudi, X. Zhou, W. Qu, Y. Lu, D.M. Stern, A.M. Schmidt, A.M. Lincoff and E.J. Topol. 2003. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 107:2238.
6. Nawroth P., A. Bierhaus, M. Marrero, H. Yamamoto and D.M. Stern. 2005. Atherosclerosis and restenosis: is there a role for RAGE? Curr. Diab. Rep. 5:11.
7. Takeda R., E. Suzuki, H. Satonaka, S. Oba, H. Nishimatsu, M. Omata, T. Fujita, R. Nagai and Y. Hirata. 2005. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation 111:1398.
8. Bierhaus A., P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D.M. Stern and P.P. Nawroth. 2005. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83:876.
9. Ramasamy R., S.F. Yan and A.M. Schmidt. 2005. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc. Med. 15:237.
10. Stern D., S.D. Yan, S.F. Yan and A.M. Schmidt. 2002. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 54:1615.
11. Hudson B.I., M.H. Stickland, T.S. Futers and P.J. Grant. 2001. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50:1505.
12. Pettersson-Fernholm K., C. Forsblom, B.I. Hudson, M. Perola, P.J. Grant and P.H. Groop; Finn-Diane Study Group. 2003. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52:891.
13. dos Santos K.G., L.H. Canani, J.L. Gross, B. Tschiedel, K.E. Pires Souto and I. Roisenberg. 2005. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 85:149.
14. Falcone C., I. Campo, E. Emanuele, M.P. Buzzi, M. Zorzetto, I. Sbarsi and M. Cuccia. 2004. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int. J. Mol. Med. 14:1061.
15. Falcone C., I. Campo, E. Emanuele, M.P. Buzzi, D. Geroldi, C. Belvito, M. Zorzetto, I. Sbarsi and M. Cuccia. 2005. -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clin. Chim. Acta 354:111.
16. Mancini G.B., S.B. Simon, M.J. McGillem, M.T. LeFree, H.Z. Friedman and R.A. Vogel. 1987. Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation 75:452.
17. Gulesserian T., C. Wenzel, G. Endler, R. Sunder-Plassmann, C. Marsik, C. Mannhalter, N. Iordanova, M. Gyongyosi, J. Wojta, S. Mustafa, O. Wagner and K. Huber. 2005. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. Clin. Chem. 51:1661.
18. Eliasson M., K. Asplund, S. Nasic and B. Rodu. 2004. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J. Intern. Med. 256:101.
19. Zambrelli E., E. Emanuele, S. Marcheselli, L. Montagna, D. Geroldi and G. Micieli. 2005. Apo(a) size in ischemic stroke: relation with subtype and severity on hospital admission. Neurology 64:1366.
20. Bauters C., E. Hubert, A. Prat, K. Bougrimi, E. Van Belle, E.P. McFadden, P. Amouyel, J.M. Lablanche and M. Bertrand. 1998. Predictors of restenosis after coronary stent implantation. J. Am. Coll. Cardiol. 31:1291.
21. de Feyter P.J., P. Kay, C. Disco and P.W. Serruys. 1999. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 100:1777.
22. Lee S.G., C.W. Lee, M.K. Hong, H.K. Park, J.J. Kim, S.W. Park and S.J. Park. 1999. Predictors of diffuse-type in-stent restenosis after coronary stent implantation. Catheter. Cardiovasc. Interv. 47:406.
23. Serruys P.W., B. van Hout, H. Bonnier et al. 1998. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352:673.
24. Hoffmann R., G.S. Mintz, G.R. Dussaillant, J.J. Popma, A.D. Pichard, L.F. Satler, K.M. Kent, J. Griffin and M.B. Leon. 1996. Patterns and mechanisms of in-stent restenosis - a serial intravascular ultrasound study. Circulation 94:1247.
25. vom Dahl J., U. Dietz, P.K. Haager, S. Silber, L. Niccoli, H.J. Buettner, F. Schiele, M. Thomas, P. Commeau, D.R. Ramsdale, E. Garcia, C.W. Hamm, R. Hoffmann, T. Reineke and H.G. Klues. 2002. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 105:583.
26. R. Albiero, S. Silber, C. di Mario, C. Cernigliaro, S. Battaglia, B. Reimers, A. Frasheri, V. Klauss, J.M. Auge, P. Rubartelli, M.C. Morice, A. Cremonesi, J. Schofer, A. Bortone and A. Colombo. 2004. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J. Am. Coll. Cardiol. 43:943.
27. Slavin L., A. Chhabra and J.M. Tobis. 2007. Drug-eluting stent. Preventing restenosis. Cardiology in Review 15:1.
28. Waksman R., E. Cheneau, A.E. Ajani, R.L. White, E. Pinnow, R. Torguson, R. Deible, L.F. Satler, A.D. Pichard, K.M. Kent, P.S. Teirstein and J. Lindsay. 2003. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 107:1744.
29. Grise M.A., V. Massullo, S. Jani, J.J. Popma, R.J. Russo, R.A. Schatz, E.M. Guarneri, S. Steuterman, D.A. Cloutier, M.B. Leon, P. Tripuraneni and P.S. Teirstein. 2002. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 105:2737.
30. Hill R.A., Y. Dundar, A. Bakhai, R. Dickson and T. Walley. 2004. Drug-eluting stents: an early systematic review to inform policy. Eur. Heart J. 25:902.
31. Katritsis D.G., E. Karvouni and J.P. Ioannidis. 2005. Meta-analysis comparing drug-eluting stents with bare metal stents. Am. J. Cardiol. 95:640.
32. Nordmann A.J., M. Briel and H.C. Bucher. 2006. Mortality in randomized controlled trials comparing drug-eluting versus bare metal stents in coronary artery disease: a meta-analysis. Eur. Heart J. 27:2784.